Tag: hurdles

STAR4BBI Market entry barriers report

STAR4BBI Market entry barriers report

Standards play a crucial role in supporting the growth of the bio-based products market. They can help to increase market transparency by providing common reference methods and requirements that enable the verification of claims and certification regarding the bio-based content, biodegradability or environmental sustainability of different products. However, inadequate standards can also act as barriers for certain products. So, what are the current EU standards or other related issues that hamper the growth of bio-based products? STAR4BBI (“Developing standards for bio-based industries”) analysed these barriers and proposed actions towards overcoming these.

The STAR4BBI market entry barriers report (D2.1) describes the market entry barriers due to regulation and standardisation that companies operating in the bio-based economy experience. The analysis is based on extensive interviews. Five main hurdles that were identified and are in detail discussed in the report are:

  • End of Life
  • Certification and Standards
  • Biofuel Policy
  • Long Term Policy
  • Communication and Image
BIO-TIC Pragmatic recommendations for action

BIO-TIC Pragmatic recommendations for action

The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations to overcome them. The projects is built on three pillars: an online industrial biotech community, an assessment of biomass and sustainability in industrial biotech, and an action plan for industrial biotech in Europe.  As part of the action plan for industrial biotech three roadmaps to overcome barriers were developed: Market roadmap, R&D roadmap and Non-Technological roadmap.

Principal barrier to European industrial biotechnology development was cost-competitiveness, both compared to fossil alternatives and compared to other regions of the world. This was affected by many factors including the cost of feedstock, technology readiness levels, and the market support for bio-based products. The cost competitiveness issue was compounded by difficulties in accessing finance for large scale projects, an often low end user awareness of IB derived products and by a lack of skills and operational alliances to drive the sector forward.

This press release discusses ten pragmatic recommendations for action to tackle identified barriers and hurdles, and to ensure that most of the market potential is realised in Europe. These cover feedstock issues (improve the opportunities for feedstock producers within the bioeconomy, investigate the scope for using novel biomass), processing issues (promote the use of co-products from processing, improve the bioconversion and downstream processing steps, identify, leverage and build upon EU capabilities for pilot and demonstration facilities), investment challenges (introduce a long-term, stable and transparent policy and incentive framework to promote the bioeconomy, and improve access to finance for large-scale projects) and support for innovation more generally (develop the skills needed now and in the future for the IB industry, assess and improve public perception and awareness of IB and bio-based products, develop stronger relationships between conventional and non-conventional players).

BIO-TIC Summary of hurdles and solutions in industrial biotechnology

BIO-TIC Summary of hurdles and solutions in industrial biotechnology

The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations to overcome them. The projects is built on three pillars: an online industrial biotech community, an assessment of biomass and sustainability in industrial biotech, and an action plan for industrial biotech in Europe.  As part of the action plan for industrial biotech three roadmaps to overcome barriers were developed: Market roadmap, R&D roadmap and Non-Technological roadmap.

This document provides a concise overview of main hurdles and solutions collected during the multi-stakeholders iterative process. Presented solutions are discussed in more depth within either the BIO-TIC R&D roadmap or the BIO-TIC non-technological roadmap.

BIO-TIC Non-technological roadmap

BIO-TIC Non-technological roadmap

The BIO-TIC project comprehensively examined the innovation hurdles in industrial biotechnology (IB) across Europe and formulated action plans and recommendations to overcome them. The projects is built on three pillars: an online industrial biotech community, an assessment of biomass and sustainability in industrial biotech, and an action plan for industrial biotech in Europe.  As part of the action plan for industrial biotech three roadmaps to overcome barriers were developed: Market roadmap, R&D roadmap and Non-Technological roadmap.

The non-technological roadmap identifies regulatory and non-technological hurdles that may prevent IB innovation from taking advantage of market opportunities., and proposes solutions for key market entry barriers.